Equities

Forecasts data is unavailable for this security.

Consensus recommendation

As of Oct 16, 2017, the consensus forecast amongst 28 polled investment analysts covering Bayer AG advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Feb 06, 2006. The previous consensus forecast advised investors to hold their position in Bayer AG.
  • 1yr ago
  • 3M ago
  • 2M ago
  • 1M ago
  • Latest
Select bar for recommendation details.
RecommendationsLatest
Buy9
Outperform5
Hold11
Underperform1
Sell1

Share price forecast

The 25 analysts offering 12 month price targets for Bayer AG have a median target of 124.00, with a high estimate of 144.00 and a low estimate of 98.00. The median estimate represents a 4.29% increase from the last price of 118.90.
High21.1%144.00
Med4.3%124.00
Low-17.6%98.00

Dividends

Dividend information is not available for Bayer AG.
Div growth (TTM)8.00%
More ▼

Earnings history & estimates

On Jul 27, 2017, Bayer AG reported 2nd quarter 2017 earnings of 1.81 per share. This result was in line with the consensus of the 10 analysts following the company and under-performed last year's 2nd quarter results by 12.56%.
The next earnings announcement is expected on Oct 26, 2017.
Average growth rate+10.40%
Bayer AG reported annual 2016 earnings of 7.32 per share on Feb 22, 2017.
The next earnings announcement from Bayer AG is expected the week of Feb 28, 2018.
Average growth rate+8.20%
More ▼

Revenue history & estimates

Bayer Aktiengesellschaft had 2nd quarter 2017 revenues of 12.19bn. This missed the 12.58bn consensus estimate of the 9 analysts following the company. This was 3.04% above the prior year's 2nd quarter results.
Average growth rate+1.06%
Bayer Aktiengesellschaft had revenues for the full year 2016 of 46.77bn. This was 0.96% above the prior year's results.
Average growth rate+4.20%
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.